Disrupting the residual triggers of COVID-19 in patients with long COVID
“Spatial transcriptomics reveals activation of SARS-CoV-2-related signaling pathways in the epipharynx of patients with long COVID”
“SARS-CoV-2 is known to bind with mitochondrial proteins in humans.
Mitochondrial dysfunction caused by COVID persists past the acute phase.
Evidence of ongoing mitochondrial and metabolic dysfunction has been found in the heart, kidneys, liver, and lymph nodes, for example.”
Studies across 14 nations show 25% to 30% rate of long COVID.
"Long COVID was defined as the presence of patient-reported symptoms 180 days after COVID-19, the authors said."